208 related articles for article (PubMed ID: 38420949)
1. Nanomaterials-Involved Tumor-Associated Macrophages' Reprogramming for Antitumor Therapy.
Li SL; Hou HY; Chu X; Zhu YY; Zhang YJ; Duan MD; Liu J; Liu Y
ACS Nano; 2024 Mar; 18(11):7769-7795. PubMed ID: 38420949
[TBL] [Abstract][Full Text] [Related]
2. Nanomaterials in modulating tumor-associated macrophages and enhancing immunotherapy.
Liang C; Zhang Y; Wang S; Jiao W; Guo J; Zhang N; Liu X
J Mater Chem B; 2024 May; 12(20):4809-4823. PubMed ID: 38695349
[TBL] [Abstract][Full Text] [Related]
3. Tumor-Associated Macrophages: Reasons to Be Cheerful, Reasons to Be Fearful.
Szulc-Kielbik I; Kielbik M
Exp Suppl; 2022; 113():107-140. PubMed ID: 35165862
[TBL] [Abstract][Full Text] [Related]
4. Engineered Bacterial Biomimetic Vesicles Reprogram Tumor-Associated Macrophages and Remodel Tumor Microenvironment to Promote Innate and Adaptive Antitumor Immune Responses.
Zheng P; He J; Fu Y; Yang Y; Li S; Duan B; Yang Y; Hu Y; Yang Z; Wang M; Liu Q; Zheng X; Hua L; Li W; Li D; Ding Y; Yang X; Bai H; Long Q; Huang W; Ma Y
ACS Nano; 2024 Mar; 18(9):6863-6886. PubMed ID: 38386537
[TBL] [Abstract][Full Text] [Related]
5. A novel insight into cancer therapy: Lipid metabolism in tumor-associated macrophages.
Ren Y; Wang M; Yuan H; Wang Z; Yu L
Int Immunopharmacol; 2024 Jun; 135():112319. PubMed ID: 38801810
[TBL] [Abstract][Full Text] [Related]
6. The role of tumor-associated macrophages in tumor immune evasion.
Huang R; Kang T; Chen S
J Cancer Res Clin Oncol; 2024 May; 150(5):238. PubMed ID: 38713256
[TBL] [Abstract][Full Text] [Related]
7. YTHDF2 orchestrates tumor-associated macrophage reprogramming and controls antitumor immunity through CD8
Ma S; Sun B; Duan S; Han J; Barr T; Zhang J; Bissonnette MB; Kortylewski M; He C; Chen J; Caligiuri MA; Yu J
Nat Immunol; 2023 Feb; 24(2):255-266. PubMed ID: 36658237
[TBL] [Abstract][Full Text] [Related]
8. The Crosstalk Between Tumor-Associated Macrophages (TAMs) and Tumor Cells and the Corresponding Targeted Therapy.
Ge Z; Ding S
Front Oncol; 2020; 10():590941. PubMed ID: 33224886
[TBL] [Abstract][Full Text] [Related]
9. Tumor Associated Macrophages, as the Dominant Immune Cells, Are an Indispensable Target for Immunologically Cold Tumor-Glioma Therapy?
Tong N; He Z; Ma Y; Wang Z; Huang Z; Cao H; Xu L; Zou Y; Wang W; Yi C; Yin Z; Wang Q
Front Cell Dev Biol; 2021; 9():706286. PubMed ID: 34368156
[TBL] [Abstract][Full Text] [Related]
10. Nanodrugs mediate TAMs-related arginine metabolism interference to boost photodynamic immunotherapy.
Chen Y; Shu X; Guo JY; Xiang Y; Liang SY; Lai JM; Zhou JY; Liu LH; Wang P
J Control Release; 2024 Mar; 367():248-264. PubMed ID: 38272398
[TBL] [Abstract][Full Text] [Related]
11. Exosome-guided direct reprogramming of tumor-associated macrophages from protumorigenic to antitumorigenic to fight cancer.
Kim H; Park HJ; Chang HW; Back JH; Lee SJ; Park YE; Kim EH; Hong Y; Kwak G; Kwon IC; Lee JE; Lee YS; Kim SY; Yang Y; Kim SH
Bioact Mater; 2023 Jul; 25():527-540. PubMed ID: 37056267
[TBL] [Abstract][Full Text] [Related]
12. Reprogramming of Tumor-Associated Macrophages with Anticancer Therapies: Radiotherapy versus Chemo- and Immunotherapies.
Genard G; Lucas S; Michiels C
Front Immunol; 2017; 8():828. PubMed ID: 28769933
[TBL] [Abstract][Full Text] [Related]
13. Embryonic Origin and Subclonal Evolution of Tumor-Associated Macrophages Imply Preventive Care for Cancer.
Zhang XM; Chen DG; Li SC; Zhu B; Li ZJ
Cells; 2021 Apr; 10(4):. PubMed ID: 33919979
[TBL] [Abstract][Full Text] [Related]
14. Tumor microenvironment remodeling and tumor therapy based on M2-like tumor associated macrophage-targeting nano-complexes.
Han S; Wang W; Wang S; Yang T; Zhang G; Wang D; Ju R; Lu Y; Wang H; Wang L
Theranostics; 2021; 11(6):2892-2916. PubMed ID: 33456579
[No Abstract] [Full Text] [Related]
15. Shaping Polarization Of Tumor-Associated Macrophages In Cancer Immunotherapy.
Gao J; Liang Y; Wang L
Front Immunol; 2022; 13():888713. PubMed ID: 35844605
[TBL] [Abstract][Full Text] [Related]
16. Nanomedicine-based cancer immunotherapies developed by reprogramming tumor-associated macrophages.
Li X; Guo X; Ling J; Tang Z; Huang G; He L; Chen T
Nanoscale; 2021 Mar; 13(9):4705-4727. PubMed ID: 33625411
[TBL] [Abstract][Full Text] [Related]
17. Targeting and repolarizing M2-like tumor-associated macrophage-mediated MR imaging and tumor immunotherapy by biomimetic nanoparticles.
Chong L; Jiang YW; Wang D; Chang P; Xu K; Li J
J Nanobiotechnology; 2023 Oct; 21(1):401. PubMed ID: 37907987
[TBL] [Abstract][Full Text] [Related]
18. Potential therapeutic targets in myeloid cell therapy for overcoming chemoresistance and immune suppression in gastrointestinal tumors.
Fan J; Zhu J; Zhu H; Xu H
Crit Rev Oncol Hematol; 2024 Jun; 198():104362. PubMed ID: 38614267
[TBL] [Abstract][Full Text] [Related]
19. Targeting lipid metabolism of macrophages: A new strategy for tumor therapy.
Shao N; Qiu H; Liu J; Xiao D; Zhao J; Chen C; Wan J; Guo M; Liang G; Zhao X; Xu L
J Adv Res; 2024 Feb; ():. PubMed ID: 38373649
[TBL] [Abstract][Full Text] [Related]
20. Gold nanoparticle-directed autophagy intervention for antitumor immunotherapy
Zhang S; Xie F; Li K; Zhang H; Yin Y; Yu Y; Lu G; Zhang S; Wei Y; Xu K; Wu Y; Jin H; Xiao L; Bao L; Xu C; Li Y; Lu Y; Gao J
Acta Pharm Sin B; 2022 Jul; 12(7):3124-3138. PubMed ID: 35865102
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
